drugset / Trial / NCT02372695
Effect of Paricalcitol Over Vessel Wall
Phase 4
Terminated
50 enrolled
Effice Servicios Para la Investigacion S.L.
Jaume Arnó Renal Foundation · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To provide evidence based prospectives of the potential benefit effects of paricalcitol, an analog of vitamin D, over the prevention / retardation of the progression of neoangiogenesis (vessels), atherosclerosis and vascular calcification.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-05
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paricalcitol | Other / unclassified | 1 ug | Oral |
Indications
No indication recorded.